Literature DB >> 9354749

Testosterone and frailty.

J E Morley1, F E Kaiser, R Sih, R Hajjar, H M Perry.   

Abstract

Although estrogen replacement therapy has become well established in the management of postmenopausal women, most physicians pay much less attention to the testosterone status of their older male patients. There is now increasing evidence that testosterone deficiency-Low Testosterone Syndrome-occurs in older men and is associated with decreased muscle strength and bone density, as well as memory problems. This article reviews the evidence for the existence of Low Testosterone Syndrome, often characterized as the male menopause or viropause, and the emerging evidence that testosterone therapy may ameliorate some of the symptoms and signs of frailty in men beyond 50 years of age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354749

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  15 in total

Review 1.  Aging-related changes in skeletal muscle. Mechanisms and interventions.

Authors:  L Larsson; B Ramamurthy
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 2.  Conceptualisation and measurement of frailty in elderly people.

Authors:  K Rockwood; D B Hogan; C MacKnight
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

3.  Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats.

Authors:  C A Frye; A M Seliga
Journal:  Cogn Affect Behav Neurosci       Date:  2001-12       Impact factor: 3.282

Review 4.  Male osteoporosis: new trends in diagnosis and therapy.

Authors:  Hosam K Kamel
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Andropause: is the emperor wearing any clothes?

Authors:  S H Tariq; M T Haren; M J Kim; J E Morley
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 6.  Frailty and hormones.

Authors:  John E Morley; Moon Jong Kim; Matthew T Haren
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

7.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

8.  Testosterone and growth hormone improve body composition and muscle performance in older men.

Authors:  Fred R Sattler; Carmen Castaneda-Sceppa; Ellen F Binder; E Todd Schroeder; Ying Wang; Shalender Bhasin; Miwa Kawakubo; Yolanda Stewart; Kevin E Yarasheski; Jagadish Ulloor; Patrick Colletti; Ronenn Roubenoff; Stanley P Azen
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

9.  Lower serum testosterone associated with elevated polychlorinated biphenyl concentrations in Native American men.

Authors:  Alexey Goncharov; Robert Rej; Serban Negoita; Maria Schymura; Azara Santiago-Rivera; Gayle Morse; David O Carpenter
Journal:  Environ Health Perspect       Date:  2009-05-20       Impact factor: 9.031

Review 10.  Androgen therapy in the aging male.

Authors:  Bruno Lunenfeld
Journal:  World J Urol       Date:  2003-10-24       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.